title: About the Rationale for Heating Oxaliplatin During HIPEC.
authors.affiliation: INSERM Unit 866 "Locoregional Therapy in Surgical Oncology", Dijon, France, Department of Medical Oncology, University Hospital of Amiens, Amiens, France Department of Digestive Surgical Oncology, University Hospital of Dijon, Dijon, France, INSERM Unit 866 "Locoregional Therapy in Surgical Oncology", Dijon, France.
authors.forename: Pablo
authors.initials: P
authors.lastname: Ortega-Deballon
authors.forename: Olivier
authors.initials: O
authors.lastname: Facy
authors.forename: Patrick
authors.initials: P
authors.lastname: Rat
authors.forename: Bruno
authors.initials: B
authors.lastname: Chauffert
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D002277:Carcinoma / Q000188:drug therapy* / Q000378:metabolism*; D006358:Hot Temperature; D008297:Male; D009944:Organoplatinum Compounds / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds